Clinical Trial Update: A PHASED, PROSPECTIVE, MULTI-CENTER STUDY OF THE ELITA SYSTEM [NA]

View source ↗

Summary

A phased, prospective, multi-center trial of the Elita System for refractive error has been terminated. The sponsor is Johnson & Johnson Surgical Vision, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Refractive Error

Drugs mentioned

• Elita System

Snippet

Sponsor: Johnson & Johnson Surgical Vision, Inc. | Conditions: Refractive Error | NA | Status: TERMINATED